ベータ
治験レーダーAI
フィルター基準に一致する試験が1件見つかりました
タイル表示

Continuous Glucose Monitoring (CGM) in Prediabetes 76 無作為化 医療機器 生活習慣 食事療法

募集中
治験(臨床試験)の詳細は主に英語で提供されていますが、治験レーダーAIがサポートします!「治験解説」をクリックして、選択した言語で試験情報を表示し、議論してください。
治験番号 NCT07371546 は 介入研究 臨床試験 で、前糖尿病 に関するものです。現在は 募集中 で、2025年10月16日 から開始しています。76 名の参加者 の募集が計画されています。この試験は SingHealth Polyclinics によって主導され、2026年12月1日 に完了予定です。ClinicalTrials.gov からの最新更新日は 2026年1月28日 です。
概要
Part 1 and 2 of study (For Patient Participants) The purpose of this study is to examine if the wearing of a medical device called a continuous glucose monitor (CGM) can guide adults with prediabetes modify their behaviors and manage their health, compared to traditional health coaching. Prediabetes means the study participants have a higher-than-normal blood sugar level which is not high enough to be considered type...もっと見る
詳細説明
BACKGROUND The World Health Organization (WHO) has identified diabetes as a priority non-communicable disease and launched initiatives to promote its prevention and management. Type-2 diabetes mellitus (T2DM) account for 90% of all global diabetes cases. Many countries have implemented national screening programs for early interventions and mitigate the associated complications. Such screening programs result in iden...もっと見る
公式タイトル

Continuous Glucose Monitoring (CGM) in Prediabetes: A Mixed-Methods Study Exploring Behavioural Impact, Patient Experiences and Provider Perspectives

疾患名
前糖尿病
刊行物
この臨床試験について発表された科学記事と研究論文:
その他の研究識別子
  • 2025-0022-APP1
NCT番号
開始日
2025-10-16
最終更新日
2026-01-28
終了予定日
2026-12
目標参加者数
76
試験の種類
介入研究
治験の相・段階
該当なし
状況
募集中
キーワード
Primary care
Continuous glucose monitoring
Behavioural change
Pre-diabetes
主目的
治療
割付方法
無作為化
介入モデル
並行割当
盲検化
単盲検
群(アーム)/介入
参加グループ/群介入/治療法
実薬対照薬Intervention
Participants in the intervention arm will wear the Abbott Freestyle Libre system for 2 weeks, in addition to usual care.
持続血糖モニタリング
Participants will also receive the Abbott Freestyle Libre system, which is a sensor-based flash glucose monitoring system that has been approved by the U.S. Food and Drug Administration for personal use by patients since September 2017 (Office of the Commissioner, 2020). Participants will also receive device-specific education and be taught how they can use CGM data to identify foods or physical activities more likel...もっと見る
非介入Control
該当なし
主要評価項目
評価指標指標の説明時間枠
Dietary intake
37-item Diet Screener (DS) The DS was designed and validated in a multi-ethnic population locally aged 18-79 years to assess intakes of selected food groups that could represent overall dietary patterns. The screener covers intakes of whole grains, soya protein, fruit, vegetables, oily fish and dairy fat and demonstrates reasonably good validity and reproducibility relative to the more accepted but longer 163-item Food Frequency Questionnaire. It is therefore easier to administer during the study with minimal participant burden.
0 weeks, 2-6 weeks, 24-28 weeks
Physical activity using International Physical Activity Questionnaire Short Form
a validated 7-item instrument that measures an individual's physical activity in the last 7 days; measures metabolic equivalent of task (MET)-minutes per week. Participants are asked to report the days and time they spent in the last 7 days in 4 categories: vigorous activity (heavy lifting, aerobics, fast bicycling), moderate activity (light lifting, moderate bicycling), walking, and sitting (watching TV, reading). The total physical activity was calculated as the sum of the vigorous, moderate, and walking categories in metabolic equivalent minutes per week (MET-min per week scores). Questions on sitting are related to sedentariness and are scored separately. MET minutes represent the amount of energy expended carrying out physical activity. One MET is what the participants expend when they rest. To get a continuous variable score it is considered walking to be 3.3 METS, moderate physical activity to be 4 METS and vigorous physical activity to be 8 METS. Higher score, better outcome.
0 weeks, 2-6 weeks, 24-28 weeks
Body weight
Weight in kilograms
0 week, 24-28 weeks
Height
Height in meters
0 week, 24-28 weeks
Body Mass Index
Weight and Height will be combined to report Body Mass Index in kg/m\^2
0 week, 24-28 weeks
Waist circumference
Waist circumference in centimeters: Waist circumference is measured at the midpoint between the lower margin of the last palpable rib and the top of the iliac crest with a measuring tape. The mean value of two waist circumference measurements is used. Both measurements are repeated if there is a difference of more than 1 cm.
0 week, 24-28 weeks
副次評価項目
評価指標指標の説明時間枠
Participant recruitment numbers
Number of participants recruited for the control and intervention arm. The study targets to recruit 76 participants over a 6-month recruitment period.
6 months recruitment period
Drop-out rate
Number of participants that dropped out of the study. Drop-out rate is calculated based on the proportion of enrolled participants who do not complete the intervention/1-month follow-up/6-month follow-up. The study targets for a drop-out rate of \< 20%.
18 months study duration
Adherence rate to the sensor
Intervention group participants usage of CGM over the two-week period. Statistics on sensor adherence will be obtained from the Abbott Freestyle Libre system and is determined as \>70% CGM use in the 2 weeks it is worn (≥10 readings over 2 weeks).
2-6 weeks
Exploring views on the facilitators and barriers of behavioral change with CGM
In-depth interviews with the intervention group participants
24-28 weeks, to allow up to 36 weeks
Views and experiences of using CGM with the Abbott Freestyle Libre system
In-depth interviews with the intervention group participants
24-28 weeks, to allow up to 36 weeks
Views and experiences on the study protocol
In-depth interviews with the intervention group participants
24-28 weeks, to allow up to 36 weeks
Experiences with managing adults with prediabetes
Interviews with HCP participants till point of data saturation
Baseline, up to 60 minutes
Knowledge and experience with CGM
Interviews with HCP participants till point of data saturation
Baseline, up to 60 minutes
Views on using CGM in adults with prediabetes
Interviews with HCP participants till point of data saturation
Baseline, up to 60 minutes
Facilitators and barriers to offering CGM as part of prediabetes management to their patients
Interviews with HCP participants till point of data saturation
Baseline, up to 60 minutes
参加アシスタント
適格基準

対象年齢
成人, 高齢者
試験の最低年齢
21 Years
対象性別
全て
Patient Participants
  1. Singaporean Citizen or Permanent Resident

  2. Age 21 - 69 years old

  3. Clinical diagnosis of prediabetes defined as a fasting glucose of 6.1-6.9 mmol/L and/or 2-hour glucose level of 7.8-11.0 mmol/L after an oral glucose tolerance test (Appropriate Care Guide, 2021)

    a. Can be conservatively managed, or medically managed with metformin

  4. Owns a mobile phone that can download the Singapore FreeStyle LibreLink App

  5. Expressed willingness to use participate in the study, use the devices according to the study protocol during the study period, and to sign informed consent.

  1. Pregnant or planned pregnancy within the next six months
  2. Physical limitation that prevents the patient from engaging in physical exercise
  3. Cognitively impaired based on diagnosis of dementia or mild cognitive impairment (MCI) in the electronic health records (EHR)
  4. Not adequately proficient in English
  5. Currently enrolled in another study or program that involves weight loss or dietary modifications, or novel therapeutic drug or device
  6. Planned surgery in the next six months
  7. Not able to use smartphone or the Singapore FreeStyle LibreLink App despite coaching
  8. Any end-stage disease with life prognosis of < 2 years
  9. Patients who are not willing or are not able to commit to the entire study program

Healthcare Providers (HCP) Participants HCPs from Pasir Ris Polyclinic who self-reported to have treated adults with prediabetes will be enrolled for the interviews.

SingHealth Polyclinics logoSingHealth Polyclinics
試験中央連絡先
連絡先: Cindy MY Wong, MBBS, Mmed (Family Medicine), +6563507600, [email protected]
2 1カ国の場所
Pasir Ris Polyclinic, Singapore, 519466, Singapore
Cindy MY Wong, MBBS, MMed (Family Medicine), 連絡先, +6563507600, [email protected]
募集中
Pasir Ris Polyclinic, Singapore, Singapore
Cindy MY Wong, 連絡先, 65-63507600, [email protected]
募集中